Source: Pharmacy Times articles
Gabriel Hinojosa, PharmD, BCOP, provides insights on selecting the best treatment regimen, and considers comorbidities, adverse events, and therapy modifications in multiple myeloma treatment.
Read More
by | Jan 24, 2024 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Gabriel Hinojosa, PharmD, BCOP, provides insights on selecting the best treatment regimen, and considers comorbidities, adverse events, and therapy modifications in multiple myeloma treatment.
Read More